Cargando…
Correlation of immune-related adverse events and response from immune checkpoint inhibitors in patients with advanced non-small cell lung cancer
Autores principales: | Sung, Mike, Zer, Alona, Walia, Preet, Khoja, Leila, Maganti, Manjula, Labbe, Catherine, Shepherd, Frances A., Bradbury, Penelope A., Liu, Geoffrey, Leighl, Natasha B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330321/ https://www.ncbi.nlm.nih.gov/pubmed/32642178 http://dx.doi.org/10.21037/jtd.2020.04.30 |
Ejemplares similares
-
Promising Targets and Current Clinical Trials in Metastatic Non-Squamous NSCLC
por: Zer, Alona, et al.
Publicado: (2014) -
The effect of prior cancer on non‐small cell lung cancer trial eligibility
por: Herman, Michael, et al.
Publicado: (2021) -
Ocular adverse events with immune checkpoint inhibitors
por: Fang, Tony, et al.
Publicado: (2019) -
Mucocutaneous adverse events to immune checkpoint inhibitors
por: Muhaj, Fiorinda, et al.
Publicado: (2023) -
Unexpected Adverse Events of Immune Checkpoint Inhibitors
por: Shalata, Walid, et al.
Publicado: (2023)